Skip to main content
OpenTrials

Clinical trial condition

Subcutaneous Emphysema

Explore clinical trials studying Subcutaneous Emphysema. Study availability and eligibility vary by location and protocol.

97 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Subcutaneous Emphysema trial results

Completed

Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency

NCT01213043

Conditions
Alpha 1-antitrypsin Deficiency (AATD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University of Florida College of Medicine Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Temple University Hosptial/Temple Lung Center Philadelphia, Pennsylvania, United States
  • Medical University of South Carolina, Division of Pulmonary and Critical Care Medicine Charleston, South Carolina, United States
View Trial Details
Completed

Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)

NCT01419158

Conditions
Alpha-1 Antitrypsin Deficiency, Chronic Disease, Chronic Obstructive Pulmonary Disease, +14 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida (Gainesville) Gainesville, Florida, United States
  • University of Florida (Jacksonville) Jacksonville, Florida, United States
View all 19 locations
View Trial Details
Completed

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

NCT00460096

Conditions
Alpha 1-Antitrypsin Deficiency, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida School of Medicine Gainesville, Florida, United States
  • The University of Texas Health Center at Tyler Tyler, Texas, United States
View Trial Details
Terminated

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

NCT04204252

Conditions
Alpha 1-Antitrypsin Deficiency, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, +9 more
Locations
  • University Hospital (UZ) Leuven Leuven, Belgium
  • Tays Central Hospital Tampere, Finland
  • Beaumont Hospital Dublin, Ireland
  • Leiden University Medical Center (LUMC) Leiden, ZA, Netherlands
View Trial Details

Related conditions